Literature DB >> 22949308

Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.

Jacqueline K Flynn1, Gregory J Dore, Gail Matthews, Margaret Hellard, Barbara Yeung, William D Rawlinson, Peter A White, John M Kaldor, Andrew R Lloyd, Rosemary A Ffrench.   

Abstract

Studies examining the effect of coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) on the HCV-specific immune response in acute HCV infection are limited. This study directly compared acute HCV-specific T-cell responses and cytokine profiles between 20 HIV/HCV-coinfected and 20 HCV-monoinfected subjects, enrolled in the Australian Trial in Acute Hepatitis C (ATAHC), using HCV peptide enzyme-linked immunospot (ELISPOT) and multiplex in vitro cytokine production assays. HIV/HCV coinfection had a detrimental effect on the HCV-specific cytokine production in acute HCV infection, particularly on HCV-specific interferon γ (IFN-γ) production (magnitude P = .004; breadth P = .046), which correlated with peripheral CD4(+) T-cell counts (ρ = 0.605; P = .005) but not with detectable HIV viremia (ρ = 0.152; P = .534).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949308      PMCID: PMC3475632          DOI: 10.1093/infdis/jis544

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Immunology. CD8 T cells remember with a little help.

Authors:  Susan M Kaech; Rafi Ahmed
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

Review 2.  A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.

Authors:  Robert Thimme; Volker Lohmann; Friedemann Weber
Journal:  Antiviral Res       Date:  2006-01-04       Impact factor: 5.970

3.  Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.

Authors:  Georg M Lauer; Tam N Nguyen; Cheryl L Day; Gregory K Robbins; Theresa Flynn; Katherine McGowan; Eric S Rosenberg; Michaela Lucas; Paul Klenerman; Raymond T Chung; Bruce D Walker
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

Authors:  Jason Grebely; Kathy Petoumenos; Margaret Hellard; Gail V Matthews; Vijayaprakash Suppiah; Tanya Applegate; Barbara Yeung; Phillipa Marks; William Rawlinson; Andrew R Lloyd; David Booth; John M Kaldor; Jacob George; Gregory J Dore
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

5.  Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.

Authors:  Aurélie Schnuriger; Stéphanie Dominguez; Marguerite Guiguet; Sawsan Harfouch; Assia Samri; Zineb Ouazene; Laurence Slama; Anne Simon; Marc-Antoine Valantin; Vincent Thibault; Brigitte Autran
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

6.  The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.

Authors:  Arthur Y Kim; Georg M Lauer; Kei Ouchi; Marylyn M Addo; Michaela Lucas; Julian Schulze Zur Wiesch; Joerg Timm; Melinda Boczanowski; Jared E Duncan; Alysse G Wurcel; Deborah Casson; Raymond T Chung; Rika Draenert; Paul Klenerman; Bruce D Walker
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

Review 7.  Hepatitis C in the HIV-Infected Person.

Authors:  Mark S Sulkowski; David L Thomas
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

8.  Diminished frequency of hepatitis C virus specific interferon gamma secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients.

Authors:  G Harcourt; E Gomperts; S Donfield; P Klenerman
Journal:  Gut       Date:  2006-03-16       Impact factor: 23.059

9.  Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

Authors:  Raymond T Chung; Janet Andersen; Paul Volberding; Gregory K Robbins; Tun Liu; Kenneth E Sherman; Marion G Peters; Margaret J Koziel; Atul K Bhan; Beverly Alston; Dodi Colquhoun; Tom Nevin; George Harb; Charles van der Horst
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

10.  Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.

Authors:  Julian Schulze Zur Wiesch; Donatella Ciuffreda; Lia Lewis-Ximenez; Victoria Kasprowicz; Brian E Nolan; Hendrik Streeck; Jasneet Aneja; Laura L Reyor; Todd M Allen; Ansgar W Lohse; Barbara McGovern; Raymond T Chung; William W Kwok; Arthur Y Kim; Georg M Lauer
Journal:  J Exp Med       Date:  2012-01-02       Impact factor: 14.307

View more
  10 in total

1.  Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.

Authors:  Chengli Shen; Phalguni Gupta; Xiaochuan Xu; Anwesha Sanyal; Charles Rinaldo; Eric Seaberg; Joseph B Margolick; Otoniel Martinez-Maza; Yue Chen
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

Review 2.  Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.

Authors:  Kara W Chew; Debika Bhattacharya
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

3.  Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.

Authors:  Jacqueline K Flynn; Gregory J Dore; Margaret Hellard; Barbara Yeung; William D Rawlinson; Peter A White; John M Kaldor; Andrew R Lloyd; Rosemary A Ffrench
Journal:  J Gastroenterol Hepatol       Date:  2013-11       Impact factor: 4.029

Review 4.  HCV and HIV co-infection: mechanisms and management.

Authors:  Jennifer Y Chen; Eoin R Feeney; Raymond T Chung
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-02-18       Impact factor: 46.802

5.  Human immunodeficiency virus and liver disease: An update.

Authors:  Kenneth E Sherman; Juergen Rockstroh; David Thomas
Journal:  Hepatology       Date:  2015-10-20       Impact factor: 17.425

6.  Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.

Authors:  Jing Qin Wu; Monica Miranda Saksena; Vincent Soriano; Eugenia Vispo; Nitin K Saksena
Journal:  Virol J       Date:  2015-01-27       Impact factor: 4.099

7.  Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.

Authors:  Amanda Whitmill; Seongcheol Kim; Vivian Rojas; Fahad Gulraiz; Kazi Afreen; Mamta Jain; Meharvan Singh; In-Woo Park
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

Review 8.  Co-infections as Modulators of Disease Outcome: Minor Players or Major Players?

Authors:  Priti Devi; Azka Khan; Partha Chattopadhyay; Priyanka Mehta; Shweta Sahni; Sachin Sharma; Rajesh Pandey
Journal:  Front Microbiol       Date:  2021-07-06       Impact factor: 5.640

9.  Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users.

Authors:  Jacqueline K Flynn; Rachel Sacks-Davis; Peter Higgs; Campbell Aitken; Sarah Moneer; Vijay Suppiah; Lilly Tracy; Rosemary Ffrench; Scott Bowden; Heidi Drummer; Jacob George; Mandvi Bharadwaj; Margaret Hellard
Journal:  Hepat Mon       Date:  2014-01-08       Impact factor: 0.660

Review 10.  Hepatitis C Virus and HIV Type 1 Co-Infection.

Authors:  Priyanka Gupta
Journal:  Infect Dis Rep       Date:  2013-06-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.